about
Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countriesShould Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost-utility analysis.Disease burden and antimicrobial resistance of invasive group B streptococcus among infants in China: a protocol for a national prospective observational studyNeonatal sepsis: an old problem with new insightsAntibody-mediated complement C3b/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border.Sepsis from the gut: the enteric habitat of bacteria that cause late-onset neonatal bloodstream infectionsBurden of invasive group B Streptococcus disease and early neurological sequelae in South African infants.Group B streptococcal infection and activation of human astrocytes.Identification of CiaR Regulated Genes That Promote Group B Streptococcal Virulence and Interaction with Brain Endothelial CellsA Novel Metallo-β-Lactamase Involved in the Ampicillin Resistance of Streptococcus pneumoniae ATCC 49136 Strain.Whole-Genome Comparison Uncovers Genomic Mutations between Group B Streptococci Sampled from Infected Newborns and Their Mothers.Estimating the burden of invasive Group B Streptococcal disease in young infants in southern mainland China: an observational studyRole of pore-forming toxins in neonatal sepsisNeonatal E. coli infection causes neuro-behavioral deficits associated with hypomyelination and neuronal sequestration of ironNeonatal severe bacterial infection impairment estimates in South Asia, sub-Saharan Africa, and Latin America for 2010Changing Epidemiology of Group B Streptococcus Susceptibility to Fluoroquinolones and Aminoglycosides in France.Immunochromatographic detection of the group B streptococcus antigen from enrichment cultures.Long-term sequelae of childhood bacterial meningitis.Long-term neurodevelopmental outcome in high-risk newborns in resource-limited settings: a systematic review of the literature.Group B streptococcal infections in the newborn infant and the potential value of maternal vaccination.Combination therapy with ampicillin and azithromycin improved outcomes in a mouse model of group B streptococcal sepsis.Group B streptococcal disease in infants in the first year of life: a nationwide surveillance study in Japan, 2011-2015.Preventing newborn infection with maternal immunization.Late and very late onset group B Streptococcus sepsis: one and the same?Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses.Cost-effectiveness of maternal GBS immunization in low-income sub-Saharan Africa.Cerebrospinal fluid procalcitonin as a biomarker of bacterial meningitis in neonates.Emergence of the L phenotype in Group B Streptococci in the South of Ireland.Incidence, etiology, and outcome of bacterial meningitis in infants aged <90 days in the United kingdom and Republic of Ireland: prospective, enhanced, national population-based surveillance.Group B Streptococcal Colonization, Molecular Characteristics, and Epidemiology.To Spinal Tap or Not To Spinal Tap, That Is the Question.Epitopes of Immunoreactive Proteins of : Enolase, Inosine 5'-Monophosphate Dehydrogenase and Molecular Chaperone GroELA mouse model reproducing the pathophysiology of neonatal group B streptococcal infection
P2860
Q28075884-5551DCDF-6FC3-4B0A-B812-B63F097959B0Q30457467-F6524FD5-6788-40F2-B235-7F6F365364FFQ33750103-1F5860E8-DE61-4C31-986E-55468114C81FQ34657130-3A1FE31D-3EED-4F35-8F5C-C3D65B248BB6Q35122775-4DFF3E63-22B1-43F7-83D6-AAB642FC8B2DQ35125020-4E05FEBF-C8B2-40BF-895D-BA8BC2C2BB10Q35306303-26A9DCB1-E018-41A9-A3C2-5EB8FA20C927Q35648179-11E16B47-3BBD-434E-98E5-24E60DF1568AQ35995811-0F9A7504-C8D2-4A48-9F7D-AC40D603CE7BQ36026754-DED3E9D3-DB87-4386-8259-CDF9E636894FQ36070056-7D776862-22BC-4E29-88B5-9FD14FBE17C3Q36183228-A7D300DC-32F7-4975-8DDB-32E28D5DE32EQ36848321-A86D869F-87C8-4229-8A0E-BBD211BBE286Q37220111-83A53FB1-7548-4D63-9D5C-451A3D198CD6Q37416034-71A3C7A2-5642-4801-AF34-FE60D6265DCBQ37428706-99B63051-C8E8-41E0-BAC1-9CBB79FBDB0AQ37469611-F4981120-98BC-42E8-9193-2AE386A9BA21Q38094111-CDD42FD0-8536-45D1-AAA8-92749B5CB84AQ38542165-7636343B-7D52-47E3-BCC5-09C3784E84A9Q38570903-A4620666-E3F8-4F66-BE76-03A3BB1A9A76Q40113070-447151CC-3FA3-4CF9-A8B7-AEB16C270495Q40318340-B1BD4987-AB2D-4B95-9733-0E61679270D3Q42253830-40B7AFAF-207C-4AA2-9033-5251ED78823AQ44794295-83324C4C-D207-4CAF-AC77-2E9A2666F844Q46353531-636EB22F-B91E-413A-A301-7D5F461EC6E1Q46543437-ECC9C7C9-2B64-44C7-B15B-CFA0897DED55Q47319429-A2AB7C17-E8F2-456D-8743-4B48AC0C8C58Q48364677-459DAAE8-99BD-4BC4-BDF8-4495C8496CFDQ51250634-6987EB2A-9EC2-4877-BCC7-8ECA7475ADB7Q52624533-9B52CB5E-8290-4720-B2B2-DED394CB28C4Q52641874-3AB0AA39-0683-4903-A8DE-4C840CAFD479Q58586144-47EEDE0B-8BEE-4E4C-9C21-0E859EDA1968Q58797746-97DCD25B-9CD2-423E-9D3F-B94B8C76E3F8
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Long-term outcomes of group B streptococcal meningitis.
@ast
Long-term outcomes of group B streptococcal meningitis.
@en
Long-term outcomes of group B streptococcal meningitis.
@nl
type
label
Long-term outcomes of group B streptococcal meningitis.
@ast
Long-term outcomes of group B streptococcal meningitis.
@en
Long-term outcomes of group B streptococcal meningitis.
@nl
prefLabel
Long-term outcomes of group B streptococcal meningitis.
@ast
Long-term outcomes of group B streptococcal meningitis.
@en
Long-term outcomes of group B streptococcal meningitis.
@nl
P2093
P356
P1433
P1476
Long-term outcomes of group B streptococcal meningitis.
@en
P2093
Carol J Baker
Fatma Levent
Luis A Castagnini
Marcia A Rench
Morven S Edwards
Prachi E Shah
Robert C Sparks
Romina Libster
Timothy Cooper
P356
10.1542/PEDS.2011-3453
P407
P577
2012-06-11T00:00:00Z